Antinuclear factor in rapid and slow acetylator patients treated with isoniazid.
作者信息
Evans D A, Bullen M F, Houston J, Hopkins C A, Vetters J M
出版信息
J Med Genet. 1972 Mar;9(1):53-6. doi: 10.1136/jmg.9.1.53.
Abstract
摘要
相似文献
1
Antinuclear factor in rapid and slow acetylator patients treated with isoniazid.接受异烟肼治疗的快乙酰化和慢乙酰化患者的抗核因子
J Med Genet. 1972 Mar;9(1):53-6. doi: 10.1136/jmg.9.1.53.
2
Effect of rifampicin and isoniazid on liver function.利福平与异烟肼对肝功能的影响。
Br Med J. 1972 Jan 15;1(5793):148-50. doi: 10.1136/bmj.1.5793.148.
3
Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.接受异烟肼治疗的患者中使用磺胺二甲嘧啶进行乙酰化表型分析。
Int J Clin Pharmacol Res. 1984;4(2):141-4.
4
5
Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
Chemotherapy. 1974;20(3):183-200. doi: 10.1159/000221808.
6
[Effectiveness of chemotherapy in patients with primary distructive tuberculosis].[化疗对原发性破坏性肺结核患者的疗效]
Probl Tuberk. 1967;45(5):21-6.
7
[Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].[初治肺结核患者的常规治疗结果]
Rev Tuberc Pneumol (Paris). 1969 Nov;33(7):967-74.
8
9
The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine.在捷克斯洛伐克使用磺胺二甲嘧啶测定结核病患者的乙酰化酶表型。
Tubercle. 1973 Mar;54(1):67-71. doi: 10.1016/0041-3879(73)90016-0.
引用本文的文献
1
Drug-induced lupus erythematosus: an update on drugs and mechanisms.药物诱导性红斑狼疮：药物和机制的最新研究进展。
Curr Opin Rheumatol. 2018 Sep;30(5):490-497. doi: 10.1097/BOR.0000000000000522.
2
Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.人类乙酰化酶多态性：利比亚等位基因频率估计及全球分布详情。
J Med Genet. 1981 Oct;18(5):325-30. doi: 10.1136/jmg.18.5.325.
3
The association of the slow acetylator phenotype with bladder cancer.慢乙酰化酶表型与膀胱癌的关联。
J Med Genet. 1983 Oct;20(5):330-3. doi: 10.1136/jmg.20.5.330.
4
Survey of the human acetylator polymorphism in spontaneous disorders.自发性疾病中人类乙酰化多态性的调查。
J Med Genet. 1984 Aug;21(4):243-53. doi: 10.1136/jmg.21.4.243.
5
Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.特异质性药物反应：风险因素的机制评估
Br J Clin Pharmacol. 1992 Nov;34(5):377-95. doi: 10.1111/j.1365-2125.1992.tb05647.x.
6
Drug-induced antinuclear antibodies and lupus syndromes.药物性抗核抗体与狼疮综合征
Drugs. 1976;12(1):69-77. doi: 10.2165/00003495-197612010-00003.
7
Sulphasalazine-induced lupus syndrome in ulcerative colitis.溃疡性结肠炎中柳氮磺胺吡啶诱发的狼疮综合征。
Br Med J. 1977 Nov 5;2(6096):1188-9. doi: 10.1136/bmj.2.6096.1188.
本文引用的文献
1
HUMAN ACETYLATION POLYMORPHISM.人类乙酰化多态性
J Lab Clin Med. 1964 Mar;63:394-403.
2
Predisposing factors in adverse reactions to drugs.药物不良反应的诱发因素。
Br Med J. 1969 Mar 1;1(5643):536-9. doi: 10.1136/bmj.1.5643.536.
3
An improved and simplified method of detecting the acetylator phenotype.一种检测乙酰化酶表型的改良简化方法。
J Med Genet. 1969 Dec;6(4):405-7. doi: 10.1136/jmg.6.4.405.
4
Induction by isoniazid and hydrallazine of antinuclear factors in mice.异烟肼和肼苯哒嗪诱导小鼠产生抗核因子。
Clin Exp Immunol. 1968 Jan;3(1):99-105.
5
Genetic variations in the acetylation of isoniazid and other drugs.异烟肼及其他药物乙酰化过程中的基因变异。
Ann N Y Acad Sci. 1968 Jul 31;151(2):723-33. doi: 10.1111/j.1749-6632.1968.tb48255.x.
6
7
Drug-induced lupus syndromes.药物性狼疮综合征
Mayo Clin Proc. 1969 Sep;44(9):664-81.
8
Autoimmune antibodies in mongol families.蒙古家族中的自身免疫抗体。
Lancet. 1967 Jul 22;2(7508):186-8. doi: 10.1016/s0140-6736(67)90008-6.
9
Possible induction of antinuclear antibodies by isoniazid.异烟肼可能诱导抗核抗体产生。
Lancet. 1966 Jan 22;1(7430):185-7. doi: 10.1016/s0140-6736(66)90704-5.
Zotero 插件